Together, our results with CRISPR targeting demonstrate that an enhancer in the SIX2-SIX3 locus linked by GWAS to diabetes and diabetes-related traits is necessary and sufficient for in situ regulation of those genes in human β-cells. This evidence concerns the gene SIX3 and diabetes mellitus.